ARMISTICE CAPITAL, LLC Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$5.6B
Holdings
116
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (116 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —STAFFING 360 SOLUTIONS INC | 5,162,720 | $3.0B | 53.07% | |
| 102 | —INMED PHARMACEUTICALS INC | 890,000 | $2.8B | 50.66% | |
| 103 | NERVGBPMINERVA NEUROSCIENCES INC | 912,000 | $2.1B | 37.88% | |
| 104 | —DIGITAL BRANDS GROUP INC | 722,890 | $1.2B | 22.00% | |
| 105 | —G MED INNOVATIONS HLDGS LTD | 1,000,000 | $1.0B | 18.53% | |
| 106 | SBEVWSPLASH BEVERAGE GROUP INC | 875,000 | $963.0M | 17.24% | |
| 107 | LEXXWLEXARIA BIOSCIENCE CORP | 361,905 | $908.0M | 16.25% | |
| 108 | —GROM SOCIAL ENTERPRISES INC | 723,000 | $723.0M | 12.94% | |
| 109 | —MEDIGUS LTD | 1,285,715 | $720.0M | 12.89% | |
| 110 | SYTAWSIYATA MOBILE INC | 150,000 | $696.0M | 12.46% | |
| 111 | BCTXWBRIACELL THERAPEUTICS CORP | 375,000 | $675.0M | 12.08% | |
| 112 | —EXELA TECHNOLOGIES INC | 200,000 | $478.0M | 8.56% | |
| 113 | —GOLD ROYALTY CORP | 448,000 | $470.0M | 8.41% | |
| 114 | —NLS PHARMACEUTICS LTD | 500,000 | $452.0M | 8.09% | |
| 115 | —AZURRX BIOPHARMA INC | 59,863 | $49.0M | 0.88% | |
| 116 | DTSTWDATA STORAGE CORP | 15,000 | $18.0M | 0.32% |
PreviousPage 2 of 2